Clinical Trials Browser

Phase 3 × Terminated × Lymphoma, B-Cell × Clear all

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00486759 2017-07-25

A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

Phase 3 Terminated

787 enrolled 8 charts

Lymphoid

Lymphoma, B-Cell

NCT00841945 2017-02-23

Treatment of Aggressive Localized Lymphoma

Phase 3 Terminated

334 enrolled

Lymphoid

Lymphoma, B-Cell

Clinical Trials

SPINOZA

A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

Treatment of Aggressive Localized Lymphoma